Skip to main content

Featured

TSX Surges Nearly 2% on Thursday as Bombardier Leads Broad Rally into May

Friday, May 1, 2026 | Canadian Money Brief | moneysavings.ca TSX Posts Strong Close to April Canada's main stock index finished April on a high note. The S&P/TSX Composite Index gained 645.94 points, or 1.9%, to close Thursday at 33,964.33. That capped a positive month for the index, with consumer, health-care, and discretionary sectors all contributing to the advance. The Canadian dollar recovered 0.47 cents to 73.62 cents U.S. Bombardier Steals the Show The session's headline mover was Bombardier. Bombardier jumped $48.59, or 20.4%, to close at $288.40 — the top of the main index — after the business jet maker beat estimates for first-quarter profit, helped by robust demand for its repair and maintenance services. On the broader earnings front, Bausch Health edged up 12 cents, or 1.7%, to $7.79, after the pharmaceutical firm's first-quarter results also beat estimates. Among notable decliners, Allied Properties REIT fell 26 cents, or 2.6%, to $9.84 after the...

article

New Cystic Fibrosis Drug Offers Hope, but Comes with a High Price

A new drug for cystic fibrosis, Trikafta, is providing significant hope for patients suffering from the genetic disorder. Trikafta has been shown to reduce hospital visits and improve overall lung function, offering patients a better quality of life. For those living with cystic fibrosis, which affects the respiratory and digestive systems, this advancement is nothing short of a breakthrough.

However, the cost of Trikafta is a major concern. Priced at around $300,000 per year, the drug is prohibitively expensive for many patients and their families. While some health programs and insurance plans may cover the cost, access to this life-changing medication remains a challenge.

As the debate over drug pricing and healthcare accessibility continues, the medical community and patient advocacy groups are calling for measures to ensure that Trikafta is available to all who need it, regardless of their financial situation.


Comments